Scientific Committee
ANTHONY BRESIN
Founder of AnBreiL
Anthony Bresin has more than 25 years of experience in the industrial biotechnology field, with expertise spanning fermentation, purification, and process scale-up from laboratory to industrial manufacturing.
He holds a Ph.D. in Industrial Fermentation on hyaluronic acid production from Reims Champagne-Ardenne University (France).
From 2000 to 2018, he served at ARD (Agro-Industrie Recherches et Développements, France), where he successively held scientific and managerial positions, ultimately as Chief Scientific Officer and Head of R&D. During this period, he led programs in fermentation, fractionation, and biopolymer development, contributing to the creation and industrialization of new bio-based molecules and polymers.
He then joined HTL (2018–2023) as Chief R&D and Validation Officer, overseeing R&D programs and technology transfers focused on biopolymers such as hyaluronic acid.
Since 2023, he has been leading AnBreiL, a biotechnology advisory firm providing scientific and strategic support in R&D, process development, and scale-up for companies active in biopolymers and fermentation-derived products.
Professor François Coutte is a professor of microbiology and molecular biology at the University of Lille, France. He obtained his PhD in biotechnology and was accredited to supervise research at the University of Lille in 2009 and 2019, respectively. Since 2010, Professor Coutte has been conducting research on the production of secondary metabolites of microbial origin at UMRt INRAE 1158 BioEcoAgro. He specialises in microbial culture processes for the production of metabolites of interest. His research focuses mainly on lipopeptides derived from Bacillus and Pseudomonas, and in particular on the various genetic, metabolic and bioprocess engineering strategies that enable their overproduction and the development of their applications. Thanks to this research, he has participated in numerous collaborative research projects at European level (H2020, INTERREG, BBI). He has also promoted and transferred part of this work to an industrial scale through the creation of the company Lipofabrik. He is currently co-director of the VALOREEMA industrial chair, which focuses on the valorisation of agricultural resources through extraction, biocatalysis or fermentation.
Nathalie Gorret is an INRAE Research Scientist at Toulouse Biotechnology Institute (TBI UMR CNRS INSA 5504 INRAe 792) since 2007. For 18 years, she developed her research within the Group Fermentation Advances and Microbial Engineering (FAME) and recently joined and co-leads the group PHYGE (Physiologie intégrée et génomique fonctionnelle des systèmes microbiens et des champignons filamenteux). Her pHD followed by a 3 years post-doctorate at MIT (Massachusetts Institute of Technology, Cambridge, USA) in Pr Sinskey’Lab (Biology Department) have contributed to developing expertise in Microbial Physiology and Biochemical Engineering, working with bacteria, yeast and plant cells for various biotechnology applications.
She joined Toulouse Biotechnology Institute in 2005 as a post-doctoral fellow to investigate the dynamics of the interaction between biological and physical phenomena observed in large-scale bioreactor. Since then, her researches focus on the understanding of the impact of heterogeneities (substrates/products/pH/dissolved oxygen/sub-populations) on the microbial behavior and strain robustness at both population and sub-population levels (physiological states / morphological states / genetic stability) using Wild Type and genetically modified strains in order to optimize microbial processes. She developed skills on methodologies and tools to characterize and quantify the transient microbial responses to environmental stresses using offline and online biosensors at both global population and single-cell levels. In addition, she develops projects focusing more specifically on biochemical engineering and the development and optimization of bioprocesses, implementing unconventional microorganisms (extremophile microorganism for example) or for specific bioproductions such as Single Cell Proteins (SCP) and lipids.
